Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Syncom Formulations Ltd.

BSE: 524470 | NSE: SYNCOMF |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE312C01025 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Feb 17, 16:01
13.70 0.14 (1.03%)
Volume
AVERAGE VOLUME
5-Day
243,143
10-Day
214,902
30-Day
228,147
176,175
  • Prev. Close

    13.56

  • Open Price

    13.41

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 17, 15:56
13.67 0.23 (1.71%)
Volume
AVERAGE VOLUME
5-Day
1,754,476
10-Day
1,795,502
30-Day
1,791,981
1,169,014
  • Prev. Close

    13.44

  • Open Price

    13.44

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    13.67 (7376)

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Strengths (13)
  • Company with high TTM EPS Growth
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 3 Years

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Weaknesses(0)

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

No data for this stock.

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Opportunities (3)
  • Companies with Price to Earnings (PE) less than average 3 Year PE, 5 Year PE and 10 Year PE
  • Above 20 DMA

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Threats (2)
  • Below 200 DMA
  • Below 50 DMA
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026